Exagen Inc. (NASDAQ:XGN) Receives Average Rating of “Moderate Buy” from Analysts

Chronological Source Flow
Back

AI Fusion Summary

Verastem Inc. (VSTM) has received a consensus "Moderate Buy" rating from brokerages. Of the ten analysts covering the company, one recommends selling, one suggests holding, six advise buying, and two assign a strong buy rating for the biopharmaceutical stock.
#Verastem #VSTM #analyst ratings #Moderate Buy #NASDAQ #biopharmaceutical #stock recommendation
05/03 08:26 defenseworld.net
5 Πηγές

Exagen Inc. (NASDAQ:XGN) Receives Average Rating of “Moderate Buy” from Analysts

05/03 08:27 defenseworld.net

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Recommendation of “Moderate Buy” from Brokerages

05/03 08:44 defenseworld.net

Verastem, Inc. (NASDAQ:VSTM) Receives Average Recommendation of “Moderate Buy” from Brokerages

05/03 10:38 defenseworld.net

Figure Technology Solutions, Inc. (NASDAQ:FIGR) Receives Average Rating of “Moderate Buy” from Analysts

05/03 10:38 defenseworld.net

Ondas Holdings Inc. (NASDAQ:ONDS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Comments
Loading...
0